Vincristine
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | ONCOVIN | — | 1982-12-09 – 2007-12-07 | fda.gov ↗ |
| Approved | US (FDA) | ONCOVIN | — | 1963-07-10 | fda.gov ↗ |
Trials 590 · started per year
Also used as a comparator or background therapy in 692 trials
Press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2000-04-05 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Completion of Novopharm Acquisition tevapharm.com ↗ |
| 2000-02-01 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries Ltd. Signs Definitive Agreement to Acquire Novopharm Ltd. tevapharm.com ↗ |
| 1999-12-02 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries Ltd. signs letter of intent to acquire Novopharm Limited tevapharm.com ↗ |
| 1999-10-19 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical confirms discussions to acquire Novopharm Ltd. tevapharm.com ↗ |
Evidence & citations 49 cited values
Every value below carries the sentence it was read from. 1,291 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vincristine | “Standard Induction chemotherapy care included: vincristine, doxorubicin, and dexamethasone (VAD) (0.5 mg, 10 mg/m2, and 40 mg, respectively);dexamethasone,...” NCT00577096 ↗1121“Control chemotherapy treatment will be chosen from any of the following standard-of-care chemotherapy drugs or combinations: * Carboplatin; * Irinotecan; * Etoposide; *...” NCT03632135 ↗ “Patients initially received one 21-day cycle of standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP; rituximab 375 mg/m2, cyclophosphamide...” PMID 30948276 ↗ Apr 2019 “One or more of the following may be assigned by the physician (physician's choice) per standard of care guidelines upon study enrollment following surgery: Cytarabine,...” NCT06861244 ↗ “Consolidation 6-thioguanine 60 mg/m2/d, 1 to 43 po; prednisone 40 mg/m2/d, on days 1-28 orally; vincristine 1.5 mg/m2/d, days 1, 8, 15, 22; idarubicin 7 mg/m2/d, on days 1, 8,...” NCT06211452 ↗ “A Phase 3 Open Label Multicenter, Randomized Study to Compare the Efficacy and Safety of the Zevalin (Ibritumomab Tiuxetan) Therapeutic Regimen Following Cyclophosphamide,...” NCT00384111 ↗ “The patients will be given RCHOP (Rituximab 375mg/m2 ivgtt, D0, Cyclophosphamide 750mg/m2, ivgtt D1, doxorubicin 50mg/m2,ivgtt D1, Vincristine 1.4mg/m2（max 2mg）, ivgtt D1...” NCT04842318 ↗ “standard CHOP chemotherapy (cyclophosphamide, 750mg per square meter of body-surface area,d1, vincristine, 1.4mg per square meter of body-surface area, maximal dose is 2mg d1,...” NCT02487316 ↗ “This study evaluates the addition of Acalabrutinib to current standard therapy of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) for patients...” NCT04546620 ↗ “The R-CHOP treatment will continue up to 3 cycles with interval of 21 days: Each cycle consists of rituximab 375mg/m2 (iv, on day 1), cyclophosphamide 750 mg/m2 (iv, on day 1),...” NCT01279902 ↗ “The purpose of the study is to assess the efficacy of the association of Lenalidomide (Revlimid) and R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, vincristine and...” NCT01393756 ↗ “bleomycin 10 units/m\^2 IV on Day 8 etoposide 200 mg/m\^2 IV on Days 1, 2 and 3 doxorubicin 35 mg/m\^2 IV on Day 1 cyclophosphamide 1250 mg/m\^2 IV on Day 1 vincristine 1.4...” NCT01118026 ↗ “All patients will receive 8 cycles of R-CHOEP immunochemotherapy every two weeks with the following doses per cycle: rituximab 375 mg/m², cyclophosphamide 750 mg/m²,...” NCT03399513 ↗ “Intrathecal administration of 2nd, 3rd, and 4th doses of methotrexate 15 mg and hydrocortisone 50mg on day 2 or 3 of 2nd, 3rd, and 4th cycles of immunochemotherapy with...” NCT03123718 ↗ “To determine the toxicity profile and tolerability of alemtuzumab (Campath) when administered in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone...” NCT00161590 ↗ “Immunochemotherapy in Primary Central Nervous System Lymphoma With Rituximab, HD-MTX, HD-Ara C, Cyclophosphamide, Ifosfamide, Vincristine, Vindesine, Temozolomide and DepoCyte...” NCT01458730 ↗ “CHOP will be given 60-120 minutes following SQ administration of Alemtuzumab as follows: cyclophosphamide 750 mg/m2 IV on day 1, doxorubicin 50 mg/m2 IV on day 1, vincristine...” NCT00323323 ↗ “rituximab and modified hyperfractionated cyclophosphamide, vincristine doxorubicin, dexamethasone (hyperCVAD) administered every 28 days for 4-6 cycles followed by rituximab...” NCT00581854 ↗ “a) Cyclophosphamide: 750 mg/m2 i.v. drip, administered on D1; b) Doxorubicin: 50 mg/m2 i.v. drip (or Epirubicin: 70mg/m2 i.v. drip), administered on D1; c) Vincristine: 1.4...” NCT06961500 ↗ “standard doses of R-CHOP21 chemotherapy (375 mg/m(2) intravenous rituximab, 750 mg/m(2) intravenous cyclophosphamide, 50 mg/m(2) intravenous doxorubicin, and 1·4 mg/m(2)...” PMID 24831981 ↗ May 2014 “VBMCP: Vincristine, 0,03 mg/Kg (iv) day 1, BCNU, 0,5 mg/Kg iv day 1, Cyclophosphamide, 10 mg/Kg iv day 1, Melfalán, 0,25 mg/Kg oral days 1 to 4 Prednisone, 1 mg/Kg oral days 1...” NCT00461747 ↗ “Eligible patients received intravenous rituximab 375 mg/m2, cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m2, and vincristine 1·4 mg/m2 (maximum 2 mg/m2), and oral prednisone...” PMID 34022150 ↗ May 2021 “Chemotherapy agents may include doxorubicin, ifosfamide, docetaxel, CHOP regimen, etoposide, cyclophosphamide and vincristine which will be administered as per standard of care...” NCT04570423 ↗ “PL-doxorubicin 35-40 mg/m(2) and epirubicin 70 mg/m(2) were given in combination with standard dosage of prednisone, vincristine, cyclophosphamide, rituximab (according to...” NCT03022123 ↗ “The purpose of the study is to determine the recommended dose (RD) of lenalidomide (Revlimid) when administered in association with R-CHOP (rituximab (R), cyclophosphamide,...” NCT00901615 ↗ “Patients received a maximum of 2 cycles of the intravenous (IV) 5-drug regimen (clofarabine, etoposide,cyclophosphamide, PEG-asparaginase, and vincristine) plus intrathecal...” NCT00991133 ↗ “Torisel in association with Rituximab-Cyclophosphamide-Doxorubicin-Vincristine-Prednisone (R-CHOP) administered every 3 weeks (21 days) for 6 cycles for patients in...” NCT01389427 ↗ “short-course chemoimmunotherapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab (CHOP-R) followed by 90-Y ibritumomab tiuxetan (RIT) with extended...” PMID 18981007 ↗ Nov 2008 “The chemotherapy entails the administration of multiple cycles of infusional doxorubicin, etoposide and vincristine chemotherapy (total of 3), alternating with cycles of...” NCT00001430 ↗ “CHOP chemotherapy will be administered at standard doses: cyclophosphamide 750 mg/m2, adriamycine 50 mg/m2, vincristine 1.4mg/m2 (maximum total dose: 2mg) and prednisone 100mg...” NCT02042391 ↗ “Patients in R-miniCHOP group will receive rituximab 375 mg/m² on day 1, cyclophosphamide 400 mg/m², doxorubicin 25 mg/m², and vincristine 1 mg on day 2, and prednisone 40 mg/m²...” NCT05179733 ↗ “Cyclophosphamide (800 mg/m2 IV over 1 hour)+ vincristine (1.5 mg/m2 IV PUSH)+ doxorubicin (40 mg/m2 IV)+ high-dose methotrexate (2,700 mg/m2 IV over 23 hours)+ rituximab (500...” NCT00392990 ↗ “R-HCVAD - Rituximab (375 mg/m2), Cyclophosphamide (300 mg/m2), Mesna (600 mg/m2), Doxorubicin (50 mg/m2), Vincristine (2 mg total), Dexamethasone (40 mg total), Methotrexate...” NCT01854372 ↗ “Six cycles of standard induction chemotherapy consisting of cyclophosphamide, vincristine, doxorubicin (or epirubicin), etoposide, and cisplatin administered according to the...” NCT07688252 ↗ “Patients with a persistently positive interim-PET scan assigned to arm B1 will receive another six cycles of the (R-)CHOP regimen (rituximab, cyclophosphamide, doxorubicine,...” NCT00554164 ↗ “Induction treatment with: 4 cycle of Vincristine (9mg/,2), Dactinomycin (6mg/m2), Doxorubicin (160mg/m2), Cyclophosphamide (2.4g/m2), Ifosfamide (18g/M2) and Etoposide...” NCT02063022 ↗ “with varied cycles, including Daunorubicin, Vincristine, Prednisone, Pegaspargase, Rituximab, Cytarabine, Mercaptopurine, Cyclophosphamide, Methotrexate, Doxorubicin,...” NCT04845035 ↗ “Used drugs are rituximab,cyclophosphamide, prednisone, dexamethasone, vincristine, methotrexate, iphosphamide, teniposide, etoposide, dexamethasone, cytarabine,adriamycin,...” NCT01290120 ↗ “cyclophosphamide, anthracene nucleus chemotherapeutics（doxorubicin，liposomal doxorubicin, etc.）, vinca alkaloids（vincristine, vindesine, etc.），and glucocorticoid...” NCT05498259 ↗ “A Pilot Study of Cyclophosphamide/Pegylated Liposomal Doxorubicin/Vincristine/Prednisone (CDOP) Plus Rituximab for Treatment of Elderly Patients With Previously Untreated...” NCT00120198 ↗ “Chemotherapy agents for reinduction include vincristine, dexamethasone, polyethylene glycol (PEG)-asparaginase (Erwinia asparaginase when PEG-asparaginase is not available),...” NCT04501614 ↗ “cisplatin 70 mg/m2 day 1, CCNU 75 mg/m2 day 1, vincristine 1.5 mg/m2 days 1, 8 and 15, Regimen B: (cycles 2, 4, 6): cyclophosphamide 1 x 1000 mg/m2 days 1-2, vincristine 1.5...” NCT02066220 ↗ “Rituximab combined with Chemotherapy (Rituximab, Cyclophosphamide, doxorubicin, Vincristine, Prednisone, Ifosfamide, Gemcitabine, cisplatin, Carboplatin, Etoposide, MESNA,...” NCT07187960 ↗ “Day 1 of each cycle will consist of an infusion of rituximab followed by the initiation of a 96-hour continuous infusion of etoposide, doxorubicin, and vincristine and oral prednisone.” NCT00799136 ↗ “Other drugs are administered at starting doses (Etoposide 50 mg/m2 (Days 1-4), Doxorubicin 10 mg/m2 (Days 1-4), Vincristine 0,4 mg/m2 (Days 1-4) and Cyclophosphamide 750 mg/m2 (Day 5).” NCT06871007 ↗ “Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (EPOCH-R) followed by idiotype vaccine and granulocyte-macrophage colony-stimulating factor (GM-CSF).” NCT00005780 ↗ “Patients received 375 mg/m(2) rituximab, 400 mg/m(2) cyclophosphamide, 25 mg/m(2) doxorubicin, and 1 mg vincristine on day 1 of each cycle, and 40 mg/m(2) prednisone on days 1-5.” PMID 21482186 ↗ Apr 2011 “Vincristine sulfate liposome injection (VSLI), a liposomal formulation of vincristine, may be better tolerated than standard aqueous vincristine and enable dose intensification.” PMID 39937083 ↗ Feb 2025 “Chemotherapy：Vincristine/paclitaxel/docetaxel/pemetrexed/gemcitabine plus cisplatin/carboplatin：administrated for patients with NSCLC requiring post-operative adjuvant therapy.” NCT05834413 ↗ “Rituximab 375 mg/m2, Cyclophosphamide 750 mg/m2, Doxorubicin 50 mg/m2 and Vincristine 1.4 mg/m2 (maximum total 2 mg) administered by IV infusion on Day 1 of each 21-day cycle.” NCT05189197 ↗ “Vincristine 1.4 mg/m2 (2 mg cap) IV on Day 1, Doxorubicin 10 mg/m2/day CIVI on Days 1-4, Etoposide 50 mg/m2/day CIVI on Days 1-4, Cyclophosphamide 750 mg/m2 IV on Day 5.” NCT04002947 ↗ “Vincristine, etoposide, carboplatin, and cyclophosphamide have been used in many protocols for brain tumors but the result was very poor in refractory or relapsed cases.” NCT01535183 ↗ “Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is one of the most effective front-line therapies to treat indolent B-cell lymphoma.” PMID 21931035 ↗ Sep 2011 “Multi-agent chemotherapy including vincristine, prednisone, daunorubicin, cyclophosphamide, pegaspargase, cytarabine, 6-MP, MTX, and dexamethasone per protocol phases.” NCT07454226 ↗ “Rituximab 375mg/m2 D1; cyclophosphamide 750mg/m2 D2; adriamycin 50 mg/m2 D2 vincristine 1.4mg/m(Max 2mg) D2; prednisone 100mg/d D2-6; Zanubrutinib 160 mg, bid D1-21” NCT06005870 ↗ “Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma” NCT00204659 ↗ “CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) is currently regarded as a standard chemotherapy regimen for patients with newly diagnosed NHL.” NCT00930605 ↗ “Intravenous administration: Rituximab 375 mg/m2, Cyclophosphamide 400 mg/m2, Doxorubicin 25 mg/m2, Vincristine 1 mg, and Oral administration: Prednisone 40 mg/m2” NCT07215585 ↗ “Specified in the protocol were vincristine/doxorubicin/dexamethasone (VAD), idarubicin/dexamethasone (ID) and cyclophosphamide/doxorubicin/dexamethasone (CAD).” NCT02288741 ↗ “Patients who are considered medical candidates for doxorubicin should receive CHOP chemotherapy (Cyclophosphamide, doxorubicin, vincristine and prednisone).” NCT00193440 ↗ “Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine” NCT03319901 ↗ “Participants will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT07443592 ↗ “Patients will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT04179929 ↗ “VDCLP regimen (vincristine, daunorubicin, cyclophosphamide, L-asparaginase, and prednisone) combined with CM313 at the RP2D during induction therapy.” NCT07585734 ↗ “Cyclophosphamide 750 mg/m2 IV, adriamycine 50 mg/m2 IV, vincristine 1.4mg/m2 IV, and prednisone 50mg/m2 PO every 3 weeks at days 50, 72, 94 and 116.” NCT01458548 ↗ “The 5 chemotherapy drugs used in the Induction part of treatment are vincristine, cisplatin, cyclophosphamide, etoposide and high-dose methotrexate.” NCT02875314 ↗ “Patients take prednisone by mouth on days 1 to 5 and etoposide, doxorubicin, and vincristine as a 96-hour infusion through a vein over days 1 to 5.” NCT00114738 ↗ “Dose Adjusted - Etoposide Prednisone Vincristine Cyclophosphamide Doxorubicin - Rituximab (DA-EPOCH-R) and nivolumab are both feasible treatments.” NCT03620578 ↗ “Cyclophosphamid 750 mg/m2, adriamycine 50 mg/m2 and vincristine 1.4mg/m2, IV and prednisone 50mg/m2, PO every 3 weeks at days 50, 72, 94 and 116.” NCT00590447 ↗ “Drug: Vincristine Vincristine will be administered at a dose of 1.4 mg/m\^2 (maximum 2 mg) IV on Day 2 of Cycle 1-6, during induction treatment.” NCT04023916 ↗ “Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma” NCT00126243 ↗ “Cyclophosphamide750mg/m2 IV, Doxorubicin 50mg/m2 IV, Vincristine 1.4mg/m2 (max 2mg) IV, Prednisone 100mg PO daily x 5 days Rituximab 375mg/m2” NCT00574730 ↗ “The mechanism of action of cidabenamide and the advantages of vincristine metronomic chemotherapy make it possible to combine the two drugs.” NCT05747313 ↗ “Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin (EPOCH) plus rituximab and campath every 3 weeks for up to 6 cycles” NCT01030900 ↗ “Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin (EPOCH) + Alemtuzumab (Campath) every 3 weeks for up to 6 cycles.” NCT00069238 ↗ “CHOP regimen(Cyclophosphamide,Vincristine,Doxorubicin,Prednisone) Cyclophosphamide 750mg/d,ivgtt, d1;Vincristine,1.4g/m2,ivgtt, d1” NCT01664975 ↗ “Treatment: rituximab 375m/m2 + ciclophosphamide 750 mg/m2 + Vincristine 1.4 mg/m2 + Doxorrubicine 50 mg/m2 at day 1 and every 14d.” NCT00849355 ↗ “3 Cycles(1 Cycle:4weeks) of Rituximab Plus CHOP (Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy” NCT03399747 ↗ “BACOPP-D regimen which includes cyclophosphamide, adriamycin, dacarbazine, procarbazine, prednisolone, bleomycin and vincristine” NCT00188149 ↗ “Yangzhengxiaoji capsule combined with CHOP regimen(Yangzhengxiaoji capsule,Cyclophosphamide,Vincristine,Doxorubicin,Prednisone)” NCT01949818 ↗ “short-course etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin with dose-dense rituximab (SC-EPOCH-RR)” PMID 20130244 ↗ Feb 2010 “During Cycle 1, participants will receive prednisone, vincristine, pegaspargase/calaspargase pegol-mknL, and daunorubicin.” NCT05326516 ↗ “HLX01 plus cyclophosphamide, doxorubicin, vincristine, and prednisone (H-CHOP) and reference rituximab plus CHOP (R-CHOP)” PMID 32299513 ↗ Apr 2020 “R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) administered in 3 week cycles for 8 cycles” NCT01865110 ↗ “conventional chemotherapy (cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone) and rituximab (R-CHOEP-14)” PMID 23168367 ↗ Nov 2012 “Cyclophosphamide 750 mg/m2, pixantrone 150 mg/m2, vincristine 1.4 mg/m2, rituximab 375 mg.m2 on Day 1 of a 21 day cycle” NCT00268853 ↗ “temozolomide: capsules, up to 200 mg/sqm/day, 5 days per cycle; PCV (procarbazine, CCNU, vincristine): standard regimen” NCT00431561 ↗ “alternating cyclophosphamide, vincristine and idarubicin alternating with another 3 cycles of carboplatin and etoposide” NCT03475121 ↗ “The CHOP include cyclophosphamide, doxorubicin/Epirubicin/liposomal doxorubicin, vincristine/Vindesine, and prednison.” NCT05933967 ↗ “patients with metastatic RMS received four cycles of ifosfamide, vincristine, and actinomycin D (IVA) plus doxorubicin” PMID 35709412 ↗ Jun 2022 “cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m2, and vincristine 1·4 mg/m2 (maximum dose 2 mg) intravenously on day 1” PMID 31126528 ↗ Jun 2019 “R-CHOP is a combination regimen consisting of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone.” NCT04661007 ↗ “Hyper-CVAD-A: Cyclophosphamide ,Vincristine , Doxorubicin , Dexamethasone ; Hyper-CVAD-B: Methotrexate , Cytarabine .” NCT07564453 ↗ “Endostar 7.5mg/m2, for iv for continuous 14 days cyclophosphamide, pirarubicin, vincristine, teniposide, prednisone” NCT01430013 ↗ “D1 : Rituximab 375 mg/m² IV + Cyclophosphamide 750 mg/m² IV + Doxorubicin 50 mg/m² IV + Vincristine 1.4 mg/m² IV.” NCT03931642 ↗ “cyclophosphamide 750 mg/m2, hydroxydoxorubicin IV 50 mg/m2, vincristine IV 1.4 mg/m2 and prednisone 100 mg daily” NCT04745832 ↗ “Chemotherapy:vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2.monthly for the first three months.” NCT05080010 ↗ “Chemotherapy:vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2.monthly for the first six months” NCT02137928 ↗ “Dexamethasone and/or vincristine and/or pegasparaginase OR cytarabine and/or etoposide and/or pegasparaginase” NCT03236857 ↗ “CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) administered in 3 week cycles for 6 cycles.” NCT01796002 ↗ “Drug :Vincristine Vincristine 1.4mg(maximum 2.0mg) per square metre (mg/m\^2),administered intravenously(IV)” NCT03485118 ↗ “Vincristine (V), intravenous injection, 1.5 mg/m2 (maximum not exceeding 2mg), D1, odd cycle administration” NCT06699472 ↗ “dose-adjusted etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab (DA-EPOCH-R)” PMID 32453640 ↗ May 2020 “receive cyclophosphamide 750 mg/m² IV, doxorubicin 50 mg/m² IV, and vincristine 1.4 mg/m² IV (maximum 2 mg)” NCT05675813 ↗ “CVAD is the acronym of the drugs in course a: cyclophosphamide, vincristine, doxorubicin and dexamethasone.” NCT05581030 ↗ “infused etoposide, doxorubicin, and cyclophosphamide with vincristine, prednisone, and rituximab (EPOCH-R)” PMID 24224624 ↗ Nov 2013 “Vincristine: A microtubule inhibitor that blocks the normal function of microtubules during cell division.” NCT06829771 ↗ “bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPPesc)” NCT01652261 ↗ “Vincristine 0.5 mg/d d 1 - 4 CI Adriamycin 10 mg/m2/d d 1 - 4 CI Dexamethasone 40 mg/d d 1-4, 9-12, 17-20” NCT00580372 ↗ “CHOP regimen includes the administrations of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.” NCT07496229 ↗ “Drug: Vincristine Vincristine (1.4mg/ m2，Max dose 2mg) will be administered by an intravenous injection” NCT06433362 ↗ “Cyclophosphamide, vincristine, high-dose methotrexate, carboplatin, etoposide, i.ventri. methotrexate” NCT07291102 ↗ “CHOP chemotherapy: cyclophosphamide, doxorubicin, vincristine, prednisone/prednisolone; 6 or 8 cycles” NCT01649856 ↗ “CEOP, cyclophosphamide 750 mg/m2, epirubicin 70 mg/m2, vincristine 1.4 mg/m2 [maximum 2 mg] on day 1” PMID 32349779 ↗ Apr 2020 “Cyclophosphamide 750 mg/m2, Doxorubicin 50 mg/m2 and Vincristine 1.4 mg/m2 up to a maximum of 2 mg” NCT02268045 ↗ “Cyclophosphamide (Cy) + Doxorubicin (ADM) + Vincristine (VDS) + Prednisone (Pred) ]± Rituximab (R)” NCT06520163 ↗ “Vincristine was administered at a dose of 1.4 mg/m\^2 IV (maximum of 2 mg) on Day 1 of each cycle.” NCT00486759 ↗ “0·4 mg/m2 per day as a continuous intravenous infusion from day 1 to day 4 (96 h) for vincristine” PMID 37011643 ↗ Mar 2023 “vincristine 1.4 mg/m2 on day 1, omitted in patients ≥70 years of age due to risk of neurotoxicity” NCT03392714 ↗ “BEACOPPescalated consisted of bleomycin 10 mg/m2 and vincristine 1·4 mg/m2 intravenously on day 8” PMID 30658935 ↗ Jan 2019 “D) Vincristine: 1.4 mg/ m2, D1 (maximum dose 2mg, maximum dose 1.5mg for age over 70 years), iv” NCT05572983 ↗ “The ALLR3 chemotherapy regimen (vincristine, mitoxantrone, dexamethasone, and PEG-asparaginase” NCT05748171 ↗ “VCAP(Vincristine Sulfate, Cyclophosphamide Hydrate, Doxorubicin Hydrochloride, Prednisolone)” NCT01173887 ↗ “R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (or prednisolone))” NCT02054559 ↗ “Etoposide, Prednisone, Doxorubicin, Cyclophosphamide, Vincristine, Rituximab, Pegfilgrastim” NCT02142049 ↗ “Drug :Vincristine 1.4mg mg/m2,administered intravenously(IV) on Day 2 of each 21-day cycle.” NCT05040906 ↗ “Cyclophosphamide, Vincristine, and Prednisone (CVP) Followed by Iodine-131 Anti-B1 Antibody” NCT01663714 ↗ “dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone” NCT05996185 ↗ “Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone” NCT06072131 ↗ “Chidamide Plus R-CHOP (Rituximab、Cyclophosphamide、Doxorubicin、Vincristine and Prednisone)” NCT06891157 ↗ “vincristine 1.4 mg/m² (dose capped at 2 mg or 1 mg for individuals above 60 years of age)” NCT04263584 ↗ “R-CHOP regimen, which includes cyclophosphamide, doxorubicin, vincristine and prednisone” NCT02012088 ↗ “The R-CHOP include rituximab, cyclophosphamide, doxorubicin, vincristine, and prednison.” NCT05234684 ↗ “* vincristine or * L-VAMP (leucovorin, vincristine, aracytin, methotrexate, prednisone)” NCT04475731 ↗ “The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma” PMID 38310286 ↗ Feb 2024 “Vincristine 1.5 milligrams per square meter per week, intravenously, day 5, 12, 19, 26” NCT02451774 ↗ “Vincristine:0.4 mg/m(2) per day continuous IV infusion over 24 hours daily on days 1-4” NCT00520130 ↗ “Vincristine, daunorubicin, cyclophosphamide, pegaspargase, prednisone, and venetoclax.” NCT07495631 ↗ “doxorubicin 50 mg/m2 day 1 vincristine 1.4 mg/m2 day 1 etoposide 100mg/m2 days 1,2,3” NCT01502982 ↗ “Vincristine1,4 mg/m2(max dose 2 mg)/ev/die 8° Procarbazine100 mg/m2/b.m./die 1°- 7°” NCT00795613 ↗ “Vincristine (V) 1.4mg/m2/day IV push with extravasation precautions on Day 1 \& 8” NCT01858922 ↗ “vincristine, cyclophosphamide, cisplatin, etoposide with or without methotrexate” NCT06193759 ↗ “Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP)” NCT05051891 ↗ “R-CHOP (Rituximab, Cyclophosphamide, doxorubicin, vincristine, and prednisone)” NCT00582725 ↗ “Vincristine: 1.4 mg/m2, up to a maximal dose of 2 mg, IV, day 2 of each cycle” NCT02772822 ↗ “chemotherapy:vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2.” NCT01899066 ↗ “Vincristine: 1.4 mg/m², intravenous administration, Day 1 (maximum dose 2 mg)” NCT07680933 ↗ “R-CHOP (Rituximab , Cyclophosphamide ,Doxorubicine ,Vincristine , Prednisone)” NCT02858258 ↗ “Vincristine: 1.4 mg/m2, up to a maximal dose of 2 mg, IV, day 2 of each cycle” NCT03650933 ↗ “doxorubicin (Adriamycin), bleomycin, vincristine (Oncovin), cyclophosphamide” PMID 28601705 ↗ Jun 2017 “rituximab, cyclophosphamide, doxorubicin, etoposide, vincristine, prednisone” NCT03293173 ↗ “R-CHOP = Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone” NCT05058404 ↗ “R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine,prednisone)” NCT03023878 ↗ “vincristine sulfate IV and bleomycin IV on day 1 of weeks 2, 4, 6, and 8” NCT00846742 ↗ “Vincristine: 0.4 mg/m2/day, in continuous 24-hour infusion, days 1 to 4” NCT01066429 ↗ “Cytoxan,Mesna,Adriamycin,Vincristine,Methotrexate,Leucovorin,Cytarabine” NCT00774332 ↗ “Regimen A:CODOX-M:cyclophosphamide,epirubicin,vincristine,methotrexate.” NCT03558412 ↗ “6 cycles of CEV chemotherapy (carboplatin, etoposide, and vincristine)” PMID 39432296 ↗ Nov 2024 “Vincristine 1.4mg/m² [max 2mg] IV day 1 + Prednisone 100mg PO days 1-5” NCT07538180 ↗ “Vincristine: 1.4mg/m2 (single maximum dose is 2mg), IV infusion, day 8” NCT02800447 ↗ “Vincristine is administered at a dose of 1.5 mg/m2 (maximum dose 2 mg)” NCT04659421 ↗ “Children's Oncology Group - Vincristine/Carboplatin (COG-V/C) regimen” NCT05566795 ↗ “Rituximab-CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone).” NCT00355199 ↗ “Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone” NCT06549595 ↗ “Vincristine (V), administered intravenously, at a dose of 1.5 mg/m2” NCT07355855 ↗ “Rituximab, Cyclophosphamide, Adriamycin, Vincristine, Prednisolone” NCT02890602 ↗ “Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone” NCT07398638 ↗ “Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone” NCT06517511 ↗ “Vincristine 1.5 mg/m\^2 (by vein)IV Push Over 15 Minutes On Day 5” NCT00500890 ↗ “Rituximab, Cyclophosphamide, doxorubicin, vincristine, prednisone” NCT03995147 ↗ “Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone” NCT06647940 ↗ “CHOP : Cyclophosphamide, Doxorubicin, Vincristine, \& Prednisone” NCT02594267 ↗ “Vincristine, 1.4 mg/m², iv day 2 or vindesine, 3mg/m², iv day 2;” NCT05428670 ↗ “Vincristine Prednis(ol)one, Cyclophosphamide, Doxorubicin, G-CSF” NCT01046825 ↗ “Vincristine: 1.4 mg/m2 IV (not to exceed 2.0 mg total) on day 1” NCT03542266 ↗ “Rituximab Doxorubicin Vincristine Cyclophosphamide Prednisolone” NCT01843868 ↗ “Vincristine: 1.4 mg/m2 IV (not to exceed 2.0 mg total) on day 3” NCT00401817 ↗ “vincristine,1.5mg/m2;carboplatin,560mg/ m2;etoposide,150 mg/ m2” NCT02319486 ↗ “Cyclophosphamide 300 mg x1; dexamethasone x 7; vincristine x1” NCT05253495 ↗ “Rituximab,Cyclophosphamide,Doxorubicin,Vincristine,Prednisone” NCT04058470 ↗ “Vincristine 1.5 mg/m2 I.V. (maximum at 2 mg) - D1, D8,D15,D22” NCT06034561 ↗ “Vincristine, IV infusion for 96 hours on days 1, 2, 3, and 4” NCT02700022 ↗ “Vincristine,1.4mg／㎡, d2（Maximum dose 2mg),intravenous drip” NCT06412068 ↗ “Cyclophosphamide, doxorubicin, vincristine, and prednisone” NCT02670317 ↗ “Vincristine: 1.4 mg/m², Day 1 (maximum single dose: 2 mg)” NCT07677813 ↗ “Vincristine + Prednisone + Olverembatinib (± Venetoclax)” NCT07493161 ↗ “Vincristine: 1.5 mg/m2 (max 2 mg) iv on days1, 8, 15, 22” NCT02396043 ↗ “Vincristine (1.5 mg/m2, i.v.; days 8, 15, 22, 29 and 36)” NCT03390387 ↗ “Augmented consolidation: vincristine, Peg-asparaginase.” NCT00222612 ↗ “Days 8/29: Vincristine 1.4 mg/m2 i.v. (capped at 2 mg),” NCT05331521 ↗ “Vinca alkaloids (Vinorelbine, Vinblastine, Vincristine)” NCT02299999 ↗ “V (Vincristine): 1.4 mg/m² (max 2 mg) on days 1 and 8.” NCT06930105 ↗ “cyclophosphamide, doxorubicin, vincristine, prednisone” NCT01459887 ↗ “Cyclophosphamide, associated on day 0 with Vincristine” NCT01516593 ↗ “Cyclophosphamide, doxorubicin, vincristine, prednisone” NCT05963347 ↗ “Vincristine is a type of drug called vinca alkaloids.” NCT00290498 ↗ “vincristine(VCR), 1.4 mg/m2 day 1 (maximal dose 2 mg)” NCT02520479 ↗ “Vincristine 1 mg i.v. (total dose), day 1, cycles 1-6” NCT04332822 ↗ “Part A: cyclophosphamide, vincristine, dexamethasone” NCT07294677 ↗ “Vincristine 1,4 mg/m² but at the maximum 2 mg,iv,d1” NCT00946374 ↗ “Vincristine 1.4 mg/m\^2 IVP (capped at 2 mg) Day 1” NCT02633137 ↗ “vincristine (1.4 mg/㎡, maximum dose 2 mg on day 1)” NCT06959732 ↗ “vincristine 1.4 mg/m2 \[capped at 2.0 mg\], iv D2” NCT03318835 ↗ “* Vincristine 1.4mg/m\^2 (dose capped at 2 mg)，D2” NCT05257018 ↗ “vincristine 1.4 mg/m2 \[capped at 2.0 mg\], iv D2” NCT04164368 ↗ “Vincristine: 1.4 g/m2, d1 (maximum dose of 2 mg)” NCT05896813 ↗ “* Vincristine sulfate (1.4 mg/m2) (2 mg maximum)” NCT02605694 ↗ “Vincristine 0.05 mg/kg IV push (max dose = 2 mg)” NCT00042367 ↗ “Vincristine(O), 1.4 mg/ m2 for injection on day1” NCT01788137 ↗ “vincristine 1.4 mg/m2 IV \[maximum total 2 mg\]” NCT06890585 ↗ “vincristine 1.4mg / m2 or vindesine 3mg / m2 d2” NCT04152577 ↗ “Vincristine: 1.5 mg/m² (maximal dose 2 mg) i.v.” NCT02265770 ↗ “cyclophosphamide, vincristine, alternate weekly” NCT05139095 ↗ “Vincristine: 1.4 mg/m² day 1 iv (max dose 2mg)” NCT02063685 ↗ “vincristine(0.022mg/kg.d or 0.67mg/m2.d，d3-d5)” NCT06933394 ↗ “Vincristine 1.4mg /m2 or Vindesine 3mg /m2 d1” NCT05097443 ↗ “Vincristine: 0.4 mg/m2 given CIV from day 1-4” NCT04992377 ↗ “Vincristine (1.4 mg/sm, max 2 mg, D 1)/cycle” NCT00842114 ↗ “Vincristine 1.4 mg/m2 IV Day 8 of each Cycle” NCT01139359 ↗ “Vincristine: 1.4 mg/m2 (max 2 mg) i.v. day 1” NCT00791947 ↗ “Intravenous Vincristine 1.4mg/m2 maximum 2mg” NCT00380770 ↗ “vincristine 1.4mg/m2 IV day1 (maximum: 2mg)” NCT01804127 ↗ “Vincristine 1.4mg/m2 or Vindesine 3mg/m2 d1” NCT05164770 ↗ “Vincristine: 1.4mg/m2, IV, d1 (maximum 2mg)” NCT05238064 ↗ “MVD: Methotrexate,Vincristine,Dexamethasone” NCT01083342 ↗ “Vincristine 1.4 mg/m² (max. 2 mg), iv Day 1” NCT07494565 ↗ “Vincristine iv 1.4 mg/m2 over 5-15 minutes” NCT00440583 ↗ “vincristine 1,4 mg/m2 (maximum 2 mg) day 1” NCT00970385 ↗ “Vincristine 1.5 mg/m2 on days 1, 8, 15, 22” NCT05827549 ↗ “vincristine, 1.4 mg/m² (max 2 mg) IV day1” NCT02445404 ↗ “* Vincristine, 2 mg/m\^2 IV bolus, day 1.” NCT01696669 ↗ “Vincristine 1.4 mg/m2 i.v.(max.2mg) day 8” NCT00433433 ↗ “Vincristine (O) 1.4mg/m2 (max 2mg) IV d1” NCT06158399 ↗ “Days 8 and 29: Vincristine 1.4 mg/m2 IV;” NCT04702581 ↗ “Vincristine 2 mg iv push (d1, 8, 15, 22)” NCT00844298 ↗ “Vincristine: 1.4 mg/m2 , iv(max：2mg), D1” NCT05093140 ↗ “Vincristine 1.4mg/ m2 (max 2mg) IV day 1” NCT00530179 ↗ “Drug: gemcitabine, vincristine,cisplatin” NCT01192633 ↗ “Vincristine 1.4mg/m2（max 2mg）, ivgtt D1” NCT04480099 ↗ “Days 8 and 29: vincristine 1.4 mg/m2 IV” NCT02444000 ↗ “vincristine IV on days 1, 8, 15, and 22” NCT00022126 ↗ “Vincristine， 1.4mg/m² ，D1 (maximum：2mg)” NCT05527912 ↗ “Vincristine 1.4mg/m2（max 2mg）, ivgtt D1” NCT05018520 ↗ “vincristine 1.4 mg/m(2) [maximum 2 mg]” PMID 26687958 ↗ Mar 2015 “Vincristine 0.7mg/m2 day every 21 days” NCT00190528 ↗ “Vincristine 1.4mg/m2(max 2mg)D1, I.V.” NCT06255704 ↗ “vincristine 1.4 mg/m2 (max 2 mg) day1” NCT06347653 ↗ “Vincristine 1.4mg/m2(max 2mg)D1, I.V.” NCT04736914 ↗ “Vincristine 2mg/day on days 6 and 13” NCT01184885 ↗ “Vincristine 0.4mg/m2/day CI24h d1-d4” NCT01818908 ↗ “Vincristine - 1.4 mg/m2 - IV - Day 1” NCT01839097 ↗ “Vincristine 1.4 mg/m2 (Max: 2 mg) d1” NCT05230680 ↗ “Vinblastine, Vincristine, Vismodegib” NCT02788201 ↗ “vincristine 0.4mg/m2/d CIV days 1-4” NCT01914718 ↗ “* Vincristine 1,4 mg/m2 i.v. day 1” NCT00466258 ↗ “Vincristine 2 mg (abs.) i.v. day 1” NCT00064116 ↗ “Vincristine: 1.4 mg/m2 ivgtt，D1 ；” NCT02526823 ↗ “Vincristine 1.4mg/m2, i.v., Day 1” NCT03151044 ↗ “Vincristine 1.4mg/m2 on Day 8 IV” NCT01304849 ↗ “vincristine 1.4 mg/m2 i.v. d 1+8” NCT00517894 ↗ “Vincristine at 25mg/m2 on day 1” NCT06290817 ↗ “Vincristine: 1.4 mg/m2, IV, d1” NCT07059650 ↗ “Vincristine 3mg/m2, d1, d15 IV” NCT05900765 ↗ “Vincristine: 1.4mg/m2, IV, d1” NCT07032532 ↗ “Drug: Vincristine Vincristine” NCT06486337 ↗ “Vincristine, IV, D1, 1.5mg/m²” NCT03011528 ↗ “* Vincristine i.v.: 1 mg (D1)” NCT05820841 ↗ “Vincristine 1 mg absolute d1)” NCT03129828 ↗ “* Vincristine * Dexamethasone” NCT00801580 ↗ “Vincristine intravenous drip” NCT06760039 ↗ “vincristine 1.4mg/m2 IV day1” NCT00854568 ↗ “Vincristine 0.4mg/ ｍ２ ，d1-4” NCT04134247 ↗ “Vincristine: 1.4g/m2 iv D1;” NCT05577364 ↗ “vincristine 2mg d1、8 ivgtt” NCT03513601 ↗ “vincristine: 1.4 mg/m2, D1” NCT06901999 ↗ “vincristine (intravenous)” NCT03181126 ↗ “Vincristine 2 mg IV 1 day” NCT02842931 ↗ “Vincristine-1.4 mg/m2 :D1” NCT01285765 ↗ “Vincristine 2 mg IV 1 day” NCT03479918 ↗ “Vincristine 1.4 mg/m2 D2” NCT06701357 ↗ “Vincristine 1.4 mg/m2 D2” NCT06750991 ↗ “Oncovin(R) (vincristine)” NCT00602667 ↗ “vincristine 1.4 mg/m² IV” NCT07706959 ↗ “Vincristine (1.4 mg/m2)” NCT06569485 ↗ “Vincristine 1,4 mg/m2 1” NCT00504491 ↗ “Oncovin(R) Vincristine” NCT00991211 ↗ “Vincristine (oncovin)®” PMID 33394214 ↗ Jan 2021 “Vincristine: 4 mg, d1” NCT05974085 ↗ “Vincristine (Oncovin)” NCT00659269 ↗ “Drug: Vincristine” NCT01014767 ↗ “Drug: Vincristine” NCT03206671 ↗ “VCR： vincristine” NCT03201471 ↗ “Vincristine” NCT03571308 ↗ “Vincristine” NCT03837873 ↗ “Vincristine” NCT00592111 ↗ |
| Known as | 22-oxovincaleukoblastine | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | 37231 | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Cellcristin | “Vincristine (Cellcristin®)” NCT02085148 ↗ |
| Known as | Kyocristine | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Leucristine | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | leurocristine | “Vincristine, also known as leurocristine and marketed under the brand name Oncovin among others, is a chemotherapy medication used to treat various types of cancer such as...” NCT04747912 ↗ |
| Known as | Leurocristine sulfate | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | LILLY-37231 | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Liposomal Vincristine | “Phase I-II Study of Liposomal Vincristine (VSLI) and Dexamethasone in Relapsed or Refractory Acute Lymphoblastic Leukemia” NCT00144963 ↗ |
| Known as | liposomal vincristine sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00335738 ↗ |
| Known as | Marqibo | “This is a pilot study utilizing Marqibo® (vincristine sulfate liposome injection) combined with dexamethasone, mitoxantrone and asparaginase (UK ALL R3) for relapsed acute...” NCT02879643 ↗5“Marqibo, a sphingosomal/cholesterol encapsulation of vincristine sulfate has targeted, increased, and sustained delivery of vincristine to tumor tissues.” PMID 19536896 ↗ Aug 2009 “Marqibo® (vincristine sulfate liposomes injection)” NCT00495079 ↗ “Vincristine Sulfate Liposomal Injection (Marqibo)” NCT04448834 ↗ “Marqibo” NCT00567567 ↗ |
| Known as | Marqibo kit | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Novopharm | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | NSC-67574 | “5-Fluorouracil, 5-FU, NSC-19893; Methyl-CCNU, MeCCNU, NSC-95441; Vincristine, VCR, NSC-67574.” NCT00427570 ↗9“Vincristine, VCR, NSC-67574” NCT00002499 ↗ “Vincristine, VCR, NSC-67574” NCT00002476 ↗ “Vincristine, VCR, NSC-67574” NCT00002471 ↗ “Vincristine, VCR, NSC-67574” NCT00002462 ↗ “VCR Vincristine, NSC-67574” NCT00002691 ↗ “VCR Vincristine, NSC-67574” NCT00002599 ↗ “VCR Vincristine, NSC-67574” NCT00001339 ↗ “VCR Vincristine, NSC-67574” NCT00002576 ↗ “VCR Vincristine, NSC-67574” NCT00002565 ↗ |
| Known as | Oncotcs | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Oncovin | “The drugs in this combination are "R" for rituximab, "C" for cyclophosphamide, "H" for doxorubicin which has a chemical name of hydroxydaunomycin, "O" for vincristine which has...” NCT02285062 ↗15“Maintenance therapy with dose-reduced POMP (purinethol [6-mercaptopurine], oncovin [vincristine sulfate], methotrexate, and prednisone) was given for 3 years.” PMID 29352703 ↗ Jan 2018 “CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)” NCT00719472 ↗ “CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)” NCT06006117 ↗ “CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)” NCT06947967 ↗ “Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone” NCT06072131 ↗ “cyclophosphamide, Oncovin [vincristine], prednisone (COP) reduction therapy” PMID 17138821 ↗ Apr 2007 “CHOP: Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone” NCT00974324 ↗ “vincristine (Oncovin), cyclophosphamide” PMID 28601705 ↗ Jun 2017 “Vincristine (oncovin)®” PMID 33394214 ↗ Jan 2021 |
| Known as | Oncovin(R) Vincristine | “Oncovin(R) (vincristine)” NCT00602667 ↗1“Oncovin(R) Vincristine” NCT00991211 ↗ |
| Known as | Tecnocris | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | VCR | “Vincristine sulfate liposome injection (VSLI,) is a sphingomyelin and cholesterol nanoparticle formulation of vincristine sulfate (VCR) that was designed to overcome the dosing...” PMID 23907766 ↗ Aug 201336“Marqibo (vincristine sulfate liposome injection, VSLI) is a novel liposomal formulation of vincristine sulfate (VCR) being developed for the systemic treatment of cancer.” PMID 20978276 ↗ Oct 2010 “Vincristine sulfate (VCR) is an inhibitor of microtubule formation in the mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage.” NCT04402073 ↗ “Participants will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT07443592 ↗ “Patients will be uniformly treated with four drug-induction: vincristine (VCR), prednisone (PDN), pegylated asparaginase (PegASP), daunorubicin (DNR).” NCT04179929 ↗ “During radiation, patients received 15 to 30 doses of carboplatin (30-45 mg/m(2)/dose), along with vincristine (VCR) once per week for 6 weeks.” PMID 22665539 ↗ Jun 2012 “Vincristine (VCR): 1.5 mg/m2 (max 2 mg) IV d 1, 8, 15, 22 in induction VCR 2 mg, IV, d 1,8 in consolidation (cycle 1, 2)” NCT00853008 ↗ “5-Fluorouracil, 5-FU, NSC-19893; Methyl-CCNU, MeCCNU, NSC-95441; Vincristine, VCR, NSC-67574.” NCT00427570 ↗ “treated with carboplatin (CBDCA) and vincristine (VCR) every 3 weeks for 24 weeks” NCT00002794 ↗ “vincristine (VCR) and daunorubicin hydrochloride (DNR) once weekly in weeks 2-5” NCT00430118 ↗ “Dex 6 mg/m2 PO; in 3 divided doses daily x 7 VCR 1.5 mg/m2 IV (max. 2.0 mg)” NCT00187057 ↗ “Vincristine (VCR ) 1.5 mg/m2 ( maximum dose 2 mg ) iv on days 1 and 8.” NCT02036489 ↗ “Vincristine (VCR): 1.5 mg/m2 (maximum 2 mg) IV days 1, 8, 15 and 22.” NCT02776605 ↗ “vincristine sulfate (VCR) IV weekly on weeks 1-10, 12, 15, and 18” NCT00002611 ↗ “Vincristine (VCR) 1.4 mg/m2 (maximum dose 2 mg) IV on D1,8,1,5,22” NCT05660473 ↗ “vincristine (VCR) IV over 3-5 minutes on days 1, 8, 15, and 22” NCT00002514 ↗ “* Vincristine (VCR) 1 mg (absolute dose) EV 1, 8, 15 and 22.” NCT01358201 ↗ “Vincristine (VCR) 1 mg (absolute dose) EV 1, 8, 15 and 22.” NCT01376427 ↗ “Vincristine (VCR): 1,5 mg/m2 i.v., days 8, 15, 22 and 28.” NCT00526175 ↗ “vincristine (VCR) on days 8, 15, 22, 29 (4 doses)” NCT01117441 ↗ “VCR (vincristine) 1.5 mg/m2 IV push (max. 2 mg)” NCT00187005 ↗ “Vincristine (VCR): 1,5 mg/m2 i.v., days 1 and 8” NCT00526305 ↗ “vincristine (VCR) IV on days 8, 15, 22, and 29” NCT00550992 ↗ “vincristine (VCR) IV on days 8, 15, 22, and 29” NCT00003728 ↗ “vincristine (VCR) IV on days 1, 8, 15, and 22” NCT00002700 ↗ “COPADM3 #1 VCR 2 mg/m2 (max 2 mg) IV day 1” NCT00187161 ↗ “vincristine (VCR) IV on day 1” NCT00002531 ↗ “Vincristine, VCR, NSC-67574” NCT00002499 ↗ “Vincristine, VCR, NSC-67574” NCT00002476 ↗ “Vincristine, VCR, NSC-67574” NCT00002471 ↗ “Vincristine, VCR, NSC-67574” NCT00002462 ↗ “VCR Vincristine, NSC-67574” NCT00002691 ↗ “VCR Vincristine, NSC-67574” NCT00002599 ↗ “VCR Vincristine, NSC-67574” NCT00002576 ↗ “VCR Vincristine, NSC-67574” NCT00002565 ↗ “Drug: Vincristine (VCR)” NCT02566993 ↗ “VCR： vincristine” NCT03201471 ↗ |
| Known as | VDS | “Cyclophosphamide (Cy) + Doxorubicin (ADM) + Vincristine (VDS) + Prednisone (Pred) ]± Rituximab (R)” NCT06520163 ↗ |
| Known as | Vincaleukoblastine, 22-oxo- | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Vincasar pfs | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Vincrex | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Vincristin | “Vincristin 1.4 mg/ms (maximum 2.0 mg total dose) iv day+1” NCT02223208 ↗12“VINCRISTIN: Dosage 1.4 mg/m2 (max. 2.0 mg/m2, IV, day 1” NCT01361191 ↗ “Vincristin 1.4mg/m2 day +1” NCT01679860 ↗ |
| Known as | Vincristin: L01CA02 | “Vincristin: L01CA02” NCT01614132 ↗ |
| Known as | Vincristina | “Rituximab: 375 mg/mq day 1 Ciclofosfamide: 750 mg/mq day 1, Vincristina: 1,4 mg/mq day 1 Prednisone: 40 mg/mq day 1-5,” NCT00774826 ↗ |
| Known as | Vincristine (Oncovin) | “Vincristine (Oncovin)” NCT01527422 ↗1“Vincristine (Oncovin)” NCT00659269 ↗ |
| Known as | Vincristine (V) | “Vincristine (V)” NCT01858922 ↗ |
| Known as | Vincristine Liposomal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03504644 ↗ |
| Known as | Vincristine PFS | “One or more of the following may be assigned by the physician (physician's choice) per standard of care guidelines upon study enrollment following surgery: Cytarabine,...” NCT06861244 ↗ |
| Known as | vincristine sulfate | “Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone, work in different ways to stop the growth of cancer cells” NCT00896519 ↗197“Maintenance therapy with dose-reduced POMP (purinethol [6-mercaptopurine], oncovin [vincristine sulfate], methotrexate, and prednisone) was given for 3 years.” PMID 29352703 ↗ Jan 2018 “Vincristine sulfate (VCR) is an inhibitor of microtubule formation in the mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage.” NCT04402073 ↗ “Vincristine sulfate was administered at a dose of 2 mg (fixed dose)” NCT01435018 ↗ “vincristine sulfate (VCR) IV weekly on weeks 1-10, 12, 15, and 18” NCT00002611 ↗ “Vincristine sulfate 1.5 mg/m2 IV will be given weekly x 6.” NCT00003203 ↗ “Vincristine Sulfate Liposomal Injection (Marqibo)” NCT04448834 ↗ “* Vincristine sulfate (1.4 mg/m2) (2 mg maximum)” NCT02605694 ↗ “vincristine sulfate IV on days 1, 8, 15, and 22” NCT00061945 ↗ “vincristine sulfate IV on days 5 and 12” NCT01412879 ↗ “vincristine (vincristine sulfate)” NCT00945009 ↗ “vincristine sulfate [vincristine]” NCT03269669 ↗ “Drug: vincristine sulfate” NCT00052936 ↗ “Drug: vincristine sulfate” NCT00002804 ↗ “Drug: vincristine sulfate” NCT00513955 ↗ “Drug: Vincristine Sulfate” NCT05761171 ↗ “Drug: vincristine sulfate” NCT00678327 ↗ “Drug: vincristine sulfate” NCT00002827 ↗ “Drug: vincristine sulfate” NCT00002756 ↗ “Drug: vincristine sulfate” NCT00138216 ↗ “Drug: vincristine sulfate” NCT00002740 ↗ “Drug: Vincristine sulfate” NCT00002715 ↗ “Drug: vincristine sulfate” NCT00003375 ↗ “Drug: vincristine sulfate” NCT00002704 ↗ “Drug: vincristine sulfate” NCT00558519 ↗ “Drug: vincristine sulfate” NCT00022126 ↗ “Drug: vincristine sulfate” NCT00005977 ↗ “Drug: vincristine sulfate” NCT00005964 ↗ “Drug: Vincristine Sulfate” NCT00653068 ↗ “Drug: vincristine sulfate” NCT00039195 ↗ “Drug: vincristine sulfate” NCT00077285 ↗ “Drug: vincristine sulfate” NCT00278408 ↗ “Drug: vincristine sulfate” NCT00039130 ↗ “Drug: vincristine sulfate” NCT00301821 ↗ “Drug: vincristine sulfate” NCT00002676 ↗ “Drug: vincristine sulfate” NCT00049036 ↗ “Drug: Vincristine Sulfate” NCT00354835 ↗ “Drug: vincristine sulfate” NCT00053768 ↗ “Drug: vincristine sulfate” NCT00002610 ↗ “Drug: Vincristine Sulfate” NCT00107198 ↗ “Drug: vincristine sulfate” NCT00043979 ↗ “Drug: Vincristine Sulfate” NCT04139304 ↗ “Drug: vincristine sulfate” NCT00002571 ↗ “Drug: vincristine sulfate” NCT00002569 ↗ “Drug: vincristine sulfate” NCT00002565 ↗ “Drug: vincristine sulfate” NCT00032019 ↗ “Drug: vincristine sulfate” NCT00666484 ↗ “Drug: vincristine sulfate” NCT00003700 ↗ “Drug: vincristine sulfate” NCT00022737 ↗ “Drug: vincristine sulfate” NCT00002875 ↗ “Drug: vincristine sulfate” NCT00049569 ↗ “Drug: vincristine sulfate” NCT00003204 ↗ “Drug: vincristine sulfate” NCT00049595 ↗ “Drug: vincristine sulfate” NCT00004228 ↗ “Drug: vincristine sulfate” NCT00003217 ↗ “Drug: vincristine sulfate” NCT00022555 ↗ “Drug: vincristine sulfate” NCT00003625 ↗ “Drug: vincristine sulfate” NCT00967057 ↗ “Drug: vincristine sulfate” NCT00020566 ↗ “Drug: vincristine sulfate” NCT00003595 ↗ “Drug: Vincristine Sulfate” NCT00002463 ↗ “Drug: vincristine sulfate” NCT00003573 ↗ “vincristine sulfate” NCT00550992 ↗ “vincristine sulfate” NCT00003541 ↗ “vincristine sulfate” NCT00024193 ↗ “vincristine sulfate” NCT00002840 ↗ “vincristine sulfate” NCT00002576 ↗ “vincristine sulfate” NCT00002499 ↗ “vincristine sulfate” NCT00417053 ↗ |
| Known as | Vincristine Sulfate For Injection | “Vincristine Sulfate For Injection 1.4mg/m2,(2mg, maximum dose), iv, d1, d8, d15, d22.” NCT02072785 ↗ |
| Known as | Vincristine sulfate liposomal | “Marqibo® (Vincristine sulfate liposomal) will be administered intravenously over 60 minutes (±10 minutes) every 7 days (±3 days) (Days 1, 8, 15, 22) for four doses (1 cycle).” NCT01222780 ↗ |
| Known as | vincristine sulfate liposomal injection | “Vincristine sulfate liposomal injection is FDA approved for the treatment of patients with recurrent Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL).” PMID 35641232 ↗ Jul 2022 |
| Known as | Vincristine Sulfate Liposome | “Drug: Vincristine Sulfate Liposome” NCT00025259 ↗ |
| Known as | Vincristine Sulfate Liposome For Injection | “Vincristine Sulfate Liposome For Injection: 1.4mg/m2, (2mg, maximum dose), iv, d1, d8, d15, d22.” NCT02072785 ↗ |
| Known as | Vincristine Sulfate Liposome Injection | “This is a pilot study utilizing Marqibo® (vincristine sulfate liposome injection) combined with dexamethasone, mitoxantrone and asparaginase (UK ALL R3) for relapsed acute...” NCT02879643 ↗ |
| Known as | Vincristine Sulfate Liposomes Injection | “Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo(Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Children and Adolescents With...” NCT01222780 ↗1“Drug: Vincristine Sulfate Liposomes Injection” NCT00144963 ↗ |
| Known as | Vincristine sulfate pfs | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Vincristine sulphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Vincristini sulfas | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Vincrisul | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | Vinkristin | ChEMBL registry synonym — accepted as the source's own label CHEMBL90555 ↗ |
| Known as | VSLI | “Vincristine sulfate liposome injection (VSLI), a liposomal formulation of vincristine, may be better tolerated than standard aqueous vincristine and enable dose intensification.” PMID 39937083 ↗ Feb 20252“Phase I-II Study of Liposomal Vincristine (VSLI) and Dexamethasone in Relapsed or Refractory Acute Lymphoblastic Leukemia” NCT00144963 ↗ “VSLI (Vincristine Sulfate Liposome Injection, 0.16 mg/mL)” NCT00145041 ↗ |
| Known as | VSLI-RTU | “Marqibo formulation and the 1-vial VSLI-RTU formulation of vincristine are administered in a 2-way crossover design over 2 treatment cycles (21 days each):” NCT04243434 ↗ |
| Action | Inhibit | “Inhibits cell mitosis causing cell death.” NCT02531308 ↗ |
| Modality | Small molecule | “vinca alkaloid” NCT01463852 ↗ |
| Route | Intravenous | “Four medicines are given on day 1 of each cycle by vein (IV) (doxorubicin, cyclophosphamide, bleomycin, vincristine).” NCT00000689 ↗ |